In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Víctor Domínguez-PrietoSurgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-1354-5056 Miguel León-ArellanoSurgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-9681-3203 Rocío Olivera-SalazarNew Therapies Laboratory, Fundación Jiménez Díaz Health Investigation Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Luz Vega-ClementeNew Therapies Laboratory, Fundación Jiménez Díaz Health Investigation Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-8558-1937 Cristina CaramésOncology Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Eva Ruiz-HispánOncology Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0009-0007-0112-5998 Raquel Fuentes-MateosOncology Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Diana Rosero-RodríguezOncology Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Héctor GuadalajaraSurgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0001-6297-9347 Mariano García-ArranzNew Therapies Laboratory, Fundación Jiménez Díaz Health Investigation Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0001-8142-1373 Damián García-OlmoSurgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-9369-2338 Funding
"Fondo de Investigaciones Sanitarias - ISCIII - FEDER", Ministry of Health, Spain (grant number PI20/01052), European Regional Development Fund PI20/01052
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
locally advanced rectal cancerrectal cancerSEPTIN9 gene methylation ratiototal neoadjuvant therapytumor response
Identifiers
PMID40149300
PMCPMC11940776
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390